Login to Your Account

Washington Roundup

Drug-Pricing Report Blames U.S. Market-Based Economy

By Mari Serebrov

Monday, July 25, 2011
A policy climate change brought on by deficit talks and health care reform could make the U.S. market-based approach to drug pricing an endangered species.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription